查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1467660

2024-2032 年按产品类型、材料类型（胶原基、氧化再生纤维素基、明胶基、多醣基等）、应用、最终用户和地区分類的止血和组织密封剂市场报告

Hemostasis and Tissue Sealing Agents Market Report by Product Type, Material Type (Collagen-based, Oxidized Regenerated Cellulose based, Gelatin-based, Polysaccharide-based, and Others), Application, End User, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 138 Pages | 商品交期: 2-3个工作天内

价格

2023年，IMARC Group止血和组织封闭剂市场规模达到68亿美元。由于外科手术数量不断增加，技术进步提高了产品功效、安全性和易用性，以及心血管疾病、癌症和糖尿病等慢性病盛行率不断上升，该市场正在经历稳定增长。

止血与组织封闭剂市场分析：

市场成长与规模：由于人们对微创 (MI) 手术的偏好不断增加，以及有利的治理倡议，市场正在经历适度成长。

技术进步：先进的生物材料、输送系统和改进的止血性能正在推动市场成长。

产业应用：止血和组织封闭剂可广泛应用于各种外科手术，包括心血管和骨科手术。

地理趋势：由于拥有高度发展的医疗基础设施、先进的医疗技术和熟练的医疗保健专业人员，北美引领市场。然而，由于医疗基础设施的改善，亚太地区正在成为一个快速成长的市场。

竞争格局：主要参与者正在投资研发 (R&D) 活动，探索新型生物材料、配方和输送系统，以提高产品功效、安全性和可用性。

挑战与机会：虽然市场面临产品安全问题等挑战，但由于人们越来越重视解决未满足的医疗需求，它也遇到了机会。

未来展望：随着老年人口的增加，止血和组织封闭剂市场的未来看起来充满希望。此外，对成本效益和基于价值的护理的需求不断增长预计将推动市场成长。

止血与组织封闭剂市场趋势：

外科手术数量不断增加

全球越来越多的外科手术正在支持止血和组织封闭剂市场的成长。人们患有各种需要手术介入的疾病。从常规手术到复杂手术，止血和组织封闭剂对于控制出血和促进癒合至关重要。此外，对有效止血和密封解决方案来解决出血併发症和改善患者治疗效果的需求不断增长，正在推动市场成长。复杂的手术通常涉及复杂的组织解剖和操作，导致出血併发症的风险较高。止血和组织封闭剂在应对这些挑战和确保成功结果方面发挥关键作用。此外，人们对 MI 手术技术（例如腹腔镜手术和机器人辅助手术）的偏好不断增加，也促进了市场的成长。虽然心肌梗塞手术具有减少创伤和加快恢復时间等优点，但它们仍然需要有效的止血控制和组织密封，而这需要专用产品的帮助。

技术进步

止血和组织封闭剂的技术创新有助于提高产品的功效、安全性和易用性。这些进步包括新型生物材料的开发、先进的输送系统和改进的止血性能。此外，引入具有优异凝血机制的止血剂和具有增强黏合性能的组织密封剂可以实现更好的止血和伤口闭合。生物相容性材料和可生物降解配方的进步解决了有关组织相容性和长期安全性的问题。此外，新颖的输送系统能够将止血剂和组织封闭剂精确地应用于手术部位。这些系统包括喷雾器、注射製剂或允许受控和有针对性地输送药剂的专用设备。标靶输送系统可提高手术效率，最大限度地减少浪费，并增强止血和组织封闭剂的有效性。除此之外，可生物降解的止血剂和组织封闭剂被设计为随着时间的推移而降解并被身体吸收，从而无需随后去除或干预。

慢性病盛行率增加

心血管疾病、癌症和糖尿病等慢性疾病的日益流行，刺激了对止血和组织封闭剂的需求。慢性病通常需要外科手术来诊断、治疗或管理。由于生活方式、环境因素和饮食习惯的改变，人们越来越多地遭受这些疾病的困扰。慢性伤口，如糖尿病性溃疡、压疮和静脉性溃疡，是慢性疾病的常见併发症，通常需要外科手术进行清创、闭合或处理。在这些手术中使用止血剂和组织封闭剂来促进止血、促进伤口闭合併加速癒合。除此之外，患有慢性疾病的患者可能会出现合併症或生理损伤，增加手术併发症的风险，包括出血和伤口癒合问题。止血和组织封闭剂透过控制出血、封闭组织和促进最佳伤口癒合，在减轻这些风险方面发挥关键作用，这支撑了市场的成长。

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球止血与组织封闭剂市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场预测

第 6 章：市场区隔：依产品类型

  • 局部止血剂
    • 市场走向
    • 市场预测
  • 黏合剂和组织密封剂
    • 市场走向
    • 市场预测

第 7 章：市场区隔：依材料类型

  • 胶原蛋白为主
    • 市场走向
    • 市场预测
  • 基于氧化再生纤维素 (ORC)
    • 市场走向
    • 市场预测
  • 明胶基
    • 市场走向
    • 市场预测
  • 多醣基
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 8 章：市场区隔：按应用

  • 一般外科
    • 市场走向
    • 市场预测
  • 微创手术
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 9 章：市场区隔：按最终用户

  • 医院
    • 市场走向
    • 市场预测
  • 门诊手术中心
    • 市场走向
    • 市场预测
  • 家庭护理设置
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 10 章：市场区隔：按地区

  • 北美洲
    • 美国
      • 市场走向
      • 市场预测
    • 加拿大
      • 市场走向
      • 市场预测
  • 亚太
    • 中国
      • 市场走向
      • 市场预测
    • 日本
      • 市场走向
      • 市场预测
    • 印度
      • 市场走向
      • 市场预测
    • 韩国
      • 市场走向
      • 市场预测
    • 澳洲
      • 市场走向
      • 市场预测
    • 印尼
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 欧洲
    • 德国
      • 市场走向
      • 市场预测
    • 法国
      • 市场走向
      • 市场预测
    • 英国
      • 市场走向
      • 市场预测
    • 义大利
      • 市场走向
      • 市场预测
    • 西班牙
      • 市场走向
      • 市场预测
    • 俄罗斯
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 拉丁美洲
    • 巴西
      • 市场走向
      • 市场预测
    • 墨西哥
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 中东和非洲
    • 市场走向
    • 市场细分：按国家/地区
    • 市场预测

第 11 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 12 章：价值链分析

第 13 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 14 章：价格分析

第15章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Advance Medical Solution Group Plc.
    • Artivion Inc.
    • B. Braun Melsungen AG
    • Baxter International Inc.
    • Becton, Dickinson & Company
    • Integra LifeSciences Corporation
    • Johnson & Johnson
    • Medtronic plc
    • Pfizer Inc.
    • Smith & Nephew plc
    • Terumo Corporation
Product Code: SR112024A6397

The global hemostasis and tissue sealing agents market size reached US$ 6.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 11.9 Billion by 2032, exhibiting a growth rate (CAGR) of 6.2% during 2024-2032. The market is experiencing steady growth driven by rising number of surgical procedures, technological advancements leading to enhanced product efficacy, safety, and ease of use, and increasing prevalence of chronic diseases, such as cardiovascular ailments, cancer, and diabetes.

Hemostasis and Tissue Sealing Agents Market Analysis:

Market Growth and Size: The market is witnessing moderate growth on account of increasing preferences for minimally invasive (MI) surgeries, along with favorable governing initiatives.

Technological Advancements: Advanced biomaterials, delivery systems, and improved hemostatic properties are propelling the market growth.

Industry Applications: Hemostasis and tissue sealing agents find applications across a wide range of surgical procedures, including cardiovascular and orthopedic.

Geographical Trends: North America leads the market, driven by the presence of highly developed healthcare infrastructure with access to advanced medical technologies and skilled healthcare professionals. However, Asia Pacific is emerging as a fast-growing market due to the improving healthcare infrastructure.

Competitive Landscape: Key players are investing in research and development (R&D) activities to explore novel biomaterials, formulations, and delivery systems for enhancing product efficacy, safety, and usability.

Challenges and Opportunities: While the market faces challenges, such as product safety concerns, it also encounters opportunities on account of the rising focus on addressing unmet medical needs.

Future Outlook: The future of the hemostasis and tissue sealing agents market looks promising with the increasing geriatric population. In addition, the rising need for cost-effectiveness and value-based care is anticipated to bolster the market growth.

Hemostasis and Tissue Sealing Agents Market Trends:

Rising number of surgical procedures

The increasing number of surgical procedures among the masses across the globe is supporting the hemostasis and tissue sealing agents market growth. People are suffering from various diseases that require surgical intervention. Hemostasis and tissue sealing agents are vital for controlling bleeding and promoting healing during various surgical interventions, ranging from routine procedures to complex surgeries. Additionally, the rising need for effective hemostatic and sealing solutions to address bleeding complications and enhance patient outcomes is propelling the market growth. Complex surgeries often involve intricate tissue dissection and manipulation, leading to a higher risk of bleeding complications. Hemostasis and tissue sealing agents play a critical role in addressing these challenges and ensuring successful outcomes. Furthermore, increasing preferences for MI surgical techniques, such as laparoscopic and robotic-assisted procedures, are contributing to the market growth. While MI surgeries offer benefits like reduced trauma and faster recovery times, they still require effective hemostatic control and tissue sealing, which are facilitated by specialized products.

Technological Advancements

Technological innovations in hemostasis and tissue sealing agents assist in enhancing product efficacy, safety, and ease of use. These advancements include the development of novel biomaterials, advanced delivery systems, and improved hemostatic properties. Moreover, the introduction of hemostatic agents with superior clotting mechanisms and tissue sealants with enhanced adhesive properties enable better hemostasis and wound closure. Advancements in biocompatible materials and biodegradable formulations address concerns regarding tissue compatibility and long-term safety. Furthermore, novel delivery systems enable the precise application of hemostasis and tissue sealing agents to the surgical site. These systems include spray applicators, injectable formulations, or specialized devices that allow for controlled and targeted delivery of the agents. Targeted delivery systems improve surgical efficiency, minimize wastage, and enhance the effectiveness of hemostasis and tissue sealing agents. Besides this, biodegradable hemostasis and tissue sealing agents are designed to degrade over time and be absorbed by the body, eliminating the need for subsequent removal or intervention.

Increasing prevalence of chronic diseases

The growing prevalence of chronic diseases, such as cardiovascular ailments, cancer, and diabetes, is catalyzing demand for hemostasis and tissue sealing agents. Chronic conditions often require surgical procedures for diagnosis, treatment, or management. People are increasingly suffering from these diseases due to changing lifestyles, environmental factors, and eating habits. Chronic wounds, such as diabetic ulcers, pressure ulcers, and venous ulcers, are common complications of chronic diseases and often require surgical intervention for debridement, closure, or management. Hemostasis and tissue sealing agents are utilized in these procedures to promote hemostasis, facilitate wound closure, and accelerate healing. Apart from this, patients with chronic diseases may present with comorbidities or physiological impairments that increase the risk of surgical complications, including bleeding and wound healing issues. Hemostasis and tissue sealing agents play a critical role in mitigating these risks by controlling bleeding, sealing tissues, and promoting optimal wound healing, which is supporting the market growth.

Hemostasis and Tissue Sealing Agents Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on product type, material type, application, and end user.

Breakup by Product Type:

Topical Hemostats

Adhesive and Tissue Sealant

Topical hemostats account for the majority of the market share

The report has provided a detailed breakup and analysis of the market based on the product type. This includes topical hemostats and adhesive and tissue sealant. According to the report, topical hemostats represented the largest segment.

Topical hemostats are agents applied directly to the bleeding site to control bleeding. They are available in various forms, such as powders, gels, sponges, and patches. These hemostats work by promoting coagulation, accelerating clot formation, or enhancing platelet aggregation to achieve hemostasis. They are particularly useful in surgical procedures where direct pressure or conventional methods may not be sufficient to achieve hemostasis.

Adhesive and tissue sealant products are used to seal tissues, close wounds, or bond tissues together. They are available in liquid, gel, or film forms and are applied directly to the tissue surface. These products contain biocompatible materials that adhere to the tissue surface and create a barrier, promoting wound healing and preventing leakage or further bleeding.

Breakup by Material Type:

Collagen-based

Oxidized Regenerated Cellulose (ORC) based

Gelatin-based

Polysaccharide-based

Others

A detailed breakup and analysis of the market based on the material type have also been provided in the report. This includes collagen-based, oxidized regenerated cellulose (ORC) based, gelatin-based, polysaccharide-based, and others.

Collagen-based hemostats utilize collagen, a protein found in connective tissues. Collagen promotes platelet adhesion and activation, initiating the clotting cascade to achieve hemostasis. Collagen-based hemostats are available in various forms, such as sponges, powders, or patches, and are widely used in surgical procedures across different specialties.

Oxidized regenerated cellulose (ORC) based hemostats are derived from cellulose, a polysaccharide found in plants. Through a process of oxidation and regeneration, cellulose is converted into ORC, which possesses hemostatic properties. ORC-based hemostats work by promoting platelet aggregation and accelerating clot formation at the bleeding site. They are available in different forms like gauzes, pads, or powders and are commonly used in surgeries where rapid hemostasis is required.

Gelatin-based hemostats are derived from collagen obtained from animal sources, usually bovine or porcine. Gelatin possesses hemostatic properties and is often combined with thrombin or other clotting factors to enhance its efficacy. These hemostats come in various forms, such as sponges, powders, or sheets, and are used in surgical procedures to control bleeding and promote wound healing.

Polysaccharide-based hemostats utilize polysaccharides, complex carbohydrates found in plants or animals. These hemostats work by promoting platelet activation and aggregation, facilitating clot formation. Polysaccharide-based hemostats include products derived from substances like chitosan, alginate, or starch. They are available in different forms like powders, gels, or films and are utilized in surgical procedures to achieve hemostasis and promote tissue sealing.

Breakup by Application:

General Surgery

Minimally Invasive Surgery

Others

General surgery represents the leading market segment

The report has provided a detailed breakup and analysis of the market based on the application. This includes general surgery, minimally invasive surgery, and others. According to the report, general surgery represented the largest segment.

General surgery encompasses a wide range of surgical procedures involving various organs and tissues within the body. These surgeries can include procedures, such as appendectomies, hernia repairs, gallbladder removals, and bowel surgeries. Hemostasis and tissue sealing agents play a crucial role in general surgery by controlling bleeding, sealing tissues, and promoting wound healing. These agents are used to manage bleeding from incisions, dissected tissues, and damaged vessels, ensuring optimal surgical outcomes and patient recovery.

Minimally invasive surgery (MIS), also known as laparoscopic or keyhole surgery, involves performing surgical procedures through small incisions using specialized instruments and a camera for visualization. MIS offers several advantages as compared to traditional open surgery, such as reduced post-operative pain, shorter hospital stays, and quicker recovery times. In minimally invasive (MI) procedures, hemostasis and tissue sealing agents are essential for controlling bleeding and sealing tissues through small incisions. These agents are applied directly to the surgical site to achieve hemostasis and ensure optimal tissue closure.

Breakup by End User:

Hospitals

Ambulatory Surgical Centers

Home Care Settings

Others

The report has provided a detailed breakup and analysis of the market based on the end user. This includes hospitals, ambulatory surgical centers, home care settings, and others.

Hospitals serve as primary settings for a wide range of medical interventions, including surgical procedures requiring hemostasis and tissue sealing agents. These facilities encompass various departments, such as operating rooms, emergency departments, and specialty units, where surgeries are performed. Hospitals have comprehensive resources, including specialized equipment, trained personnel, and integrated healthcare services, making them key users of hemostasis and tissue sealing agents. These agents are used across different surgical specialties within hospital settings to control bleeding, seal tissues, and promote wound healing.

Ambulatory surgical centers (ACSs), also known as outpatient surgery centers or day surgery centers, provide surgical services on an outpatient basis, allowing patients to undergo procedures without overnight hospitalization. ASCs offer a convenient and cost-effective alternative to traditional hospital-based surgeries, particularly for minor or elective procedures. In ASCs, hemostasis and tissue sealing agents are utilized to control bleeding and promote wound closure during various surgical interventions. These centers often specialize in specific surgical specialties, such as ophthalmology, orthopedics, or gastroenterology, where hemostasis and tissue sealing agents are routinely used to ensure safe and efficient surgical outcomes.

Home care settings involve the provision of medical care, including post-operative care, within the home of patients. Hemostasis and tissue sealing agents are used to address wound complications, promote healing, and prevent infections, ensuring continuity of care and facilitating the recovery process of patients within the comfort of their homes.

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America leads the market, accounting for the largest hemostasis and tissue sealing agents market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share due to the presence of highly developed healthcare infrastructure, with access to advanced medical technologies and skilled healthcare professionals. Additionally, the rising number of surgical procedures among individuals is bolstering the market growth.

Asia Pacific stands as another key region in the market, driven by the increasing adoption of MI surgeries among the masses. In addition, improving healthcare infrastructure is contributing to the growth of the market.

Europe maintains a strong presence in the market, with the rising prevalence of chronic diseases among individuals. Besides this, stringent standards for the approval and marketing of medical devices, including hemostasis and tissue sealing agents, are impelling the market growth.

Latin America exhibits the growing potential in the market on account of the increasing need for hemostasis and tissue sealing agents during surgical interventions. Furthermore, the rising awareness among healthcare professionals and patients about the benefits of advanced surgical techniques and medical products is bolstering the market growth.

The Middle East and Africa region is primarily driven by improving healthcare infrastructure. Moreover, thriving medical tourism in the region is propelling the market growth.

Leading Key Players in the Hemostasis and Tissue Sealing Agents Industry:

Key players are investing in R&D activities to explore novel biomaterials, formulations, and delivery systems to enhance product efficacy, safety, and usability. They are continuously innovating their product offerings to meet the diverse needs of healthcare providers and patients by developing advanced hemostatic agents and tissue sealants with enhanced hemostatic properties, faster sealing times, and improved biocompatibility. In addition, companies are expanding the indications for their hemostasis and tissue sealing agents, making them applicable to a wider range of surgical procedures. This involves obtaining regulatory approvals for new indications and conducting clinical trials to demonstrate product efficacy and safety in different surgical specialties. Furthermore, companies are expanding their market reach by entering new geographical regions.

The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Advance Medical Solution Group Plc.

Artivion Inc.

B. Braun Melsungen AG

Baxter International Inc.

Becton, Dickinson & Company

Integra LifeSciences Corporation

Johnson & Johnson

Medtronic plc

Pfizer Inc.

Smith & Nephew plc

Terumo Corporation

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

Latest News:

July 29, 2021: Baxter International Inc completed the acquisition of certain assets related to PerClot polysaccharide hemostatic system from CryoLife, Inc. PerClot further enhances the ability of the company to optimize patient care by addressing a broad range of intraoperative bleeding with both active and passive hemostatic solutions.

November 15, 2023: Johnson & Johnson MedTech company 'Ethicon' announced the approval of ETHIZIATM, an adjunctive hemostat solution, which is clinically proven to achieve sustained hemostasis in difficult to control bleeding situations.

February 26, 2020: Terumo Corporation launched AQUABRID(R) a new surgical sealant especially developed for aortic procedures. It reacts with blood and forms an elastic layer that adheres tightly to the tissue. It is safe and effective in achieving hemostasis, even when blood coagulation is inhibited during cardiac surgery.

Key Questions Answered in This Report

  • 1. What was the size of the global hemostasis and tissue sealing agents market in 2023?
  • 2. What is the expected growth rate of the global hemostasis and tissue sealing agents market during 2024-2032?
  • 3. What are the key factors driving the global hemostasis and tissue sealing agents market?
  • 4. What has been the impact of COVID-19 on the global hemostasis and tissue sealing agents market?
  • 5. What is the breakup of the global hemostasis and tissue sealing agents market based on the product type?
  • 6. What is the breakup of the global hemostasis and tissue sealing agents market based on the application?
  • 7. What are the key regions in the global hemostasis and tissue sealing agents market?
  • 8. Who are the key players/companies in the global hemostasis and tissue sealing agents market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Hemostasis and Tissue Sealing Agents Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Topical Hemostats
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Adhesive and Tissue Sealant
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Material Type

  • 7.1 Collagen-based
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Oxidized Regenerated Cellulose (ORC) based
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Gelatin-based
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Polysaccharide-based
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by Application

  • 8.1 General Surgery
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Minimally Invasive Surgery
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Hospitals
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Ambulatory Surgical Centers
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Home Care Settings
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Advance Medical Solution Group Plc.
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Artivion Inc.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 B. Braun Melsungen AG
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
    • 15.3.4 Baxter International Inc.
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5 Becton, Dickinson & Company
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6 Integra LifeSciences Corporation
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Johnson & Johnson
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Medtronic plc
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Pfizer Inc.
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Smith & Nephew plc
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis
    • 15.3.11 Terumo Corporation
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
      • 15.3.11.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Hemostasis and Tissue Sealing Agents Market: Major Drivers and Challenges
  • Figure 2: Global: Hemostasis and Tissue Sealing Agents Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Hemostasis and Tissue Sealing Agents Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Hemostasis and Tissue Sealing Agents Market: Breakup by Product Type (in %), 2023
  • Figure 5: Global: Hemostasis and Tissue Sealing Agents Market: Breakup by Material Type (in %), 2023
  • Figure 6: Global: Hemostasis and Tissue Sealing Agents Market: Breakup by Application (in %), 2023
  • Figure 7: Global: Hemostasis and Tissue Sealing Agents Market: Breakup by End User (in %), 2023
  • Figure 8: Global: Hemostasis and Tissue Sealing Agents Market: Breakup by Region (in %), 2023
  • Figure 9: Global: Hemostasis and Tissue Sealing Agents (Topical Hemostats) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Hemostasis and Tissue Sealing Agents (Topical Hemostats) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Hemostasis and Tissue Sealing Agents (Adhesive and Tissue Sealant) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Hemostasis and Tissue Sealing Agents (Adhesive and Tissue Sealant) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Hemostasis and Tissue Sealing Agents (Collagen-based) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Hemostasis and Tissue Sealing Agents (Collagen-based) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Hemostasis and Tissue Sealing Agents (Oxidized Regenerated Cellulose (ORC) based) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Hemostasis and Tissue Sealing Agents (Oxidized Regenerated Cellulose (ORC) based) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Hemostasis and Tissue Sealing Agents (Gelatin-based) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Hemostasis and Tissue Sealing Agents (Gelatin-based) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Hemostasis and Tissue Sealing Agents (Polysaccharide-based) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Hemostasis and Tissue Sealing Agents (Polysaccharide-based) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Hemostasis and Tissue Sealing Agents (Other Material Types) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Hemostasis and Tissue Sealing Agents (Other Material Types) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Hemostasis and Tissue Sealing Agents (General Surgery) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Hemostasis and Tissue Sealing Agents (General Surgery) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: Hemostasis and Tissue Sealing Agents (Minimally Invasive Surgery) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: Hemostasis and Tissue Sealing Agents (Minimally Invasive Surgery) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Global: Hemostasis and Tissue Sealing Agents (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Global: Hemostasis and Tissue Sealing Agents (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Global: Hemostasis and Tissue Sealing Agents (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Global: Hemostasis and Tissue Sealing Agents (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: Global: Hemostasis and Tissue Sealing Agents (Ambulatory Surgical Centers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: Global: Hemostasis and Tissue Sealing Agents (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: Global: Hemostasis and Tissue Sealing Agents (Home Care Settings) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: Global: Hemostasis and Tissue Sealing Agents (Home Care Settings) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: Global: Hemostasis and Tissue Sealing Agents (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: Global: Hemostasis and Tissue Sealing Agents (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: North America: Hemostasis and Tissue Sealing Agents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: North America: Hemostasis and Tissue Sealing Agents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: United States: Hemostasis and Tissue Sealing Agents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: United States: Hemostasis and Tissue Sealing Agents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: Canada: Hemostasis and Tissue Sealing Agents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: Canada: Hemostasis and Tissue Sealing Agents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: Asia-Pacific: Hemostasis and Tissue Sealing Agents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: Asia-Pacific: Hemostasis and Tissue Sealing Agents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: China: Hemostasis and Tissue Sealing Agents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: China: Hemostasis and Tissue Sealing Agents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: Japan: Hemostasis and Tissue Sealing Agents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: Japan: Hemostasis and Tissue Sealing Agents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: India: Hemostasis and Tissue Sealing Agents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: India: Hemostasis and Tissue Sealing Agents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: South Korea: Hemostasis and Tissue Sealing Agents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: South Korea: Hemostasis and Tissue Sealing Agents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: Australia: Hemostasis and Tissue Sealing Agents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: Australia: Hemostasis and Tissue Sealing Agents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: Indonesia: Hemostasis and Tissue Sealing Agents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: Indonesia: Hemostasis and Tissue Sealing Agents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: Others: Hemostasis and Tissue Sealing Agents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: Others: Hemostasis and Tissue Sealing Agents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: Europe: Hemostasis and Tissue Sealing Agents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: Europe: Hemostasis and Tissue Sealing Agents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: Germany: Hemostasis and Tissue Sealing Agents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: Germany: Hemostasis and Tissue Sealing Agents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: France: Hemostasis and Tissue Sealing Agents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: France: Hemostasis and Tissue Sealing Agents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: United Kingdom: Hemostasis and Tissue Sealing Agents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: United Kingdom: Hemostasis and Tissue Sealing Agents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: Italy: Hemostasis and Tissue Sealing Agents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: Italy: Hemostasis and Tissue Sealing Agents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: Spain: Hemostasis and Tissue Sealing Agents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: Spain: Hemostasis and Tissue Sealing Agents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: Russia: Hemostasis and Tissue Sealing Agents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 72: Russia: Hemostasis and Tissue Sealing Agents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: Others: Hemostasis and Tissue Sealing Agents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 74: Others: Hemostasis and Tissue Sealing Agents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Latin America: Hemostasis and Tissue Sealing Agents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 76: Latin America: Hemostasis and Tissue Sealing Agents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: Brazil: Hemostasis and Tissue Sealing Agents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 78: Brazil: Hemostasis and Tissue Sealing Agents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 79: Mexico: Hemostasis and Tissue Sealing Agents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 80: Mexico: Hemostasis and Tissue Sealing Agents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 81: Others: Hemostasis and Tissue Sealing Agents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 82: Others: Hemostasis and Tissue Sealing Agents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 83: Middle East and Africa: Hemostasis and Tissue Sealing Agents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 84: Middle East and Africa: Hemostasis and Tissue Sealing Agents Market: Breakup by Country (in %), 2023
  • Figure 85: Middle East and Africa: Hemostasis and Tissue Sealing Agents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 86: Global: Hemostasis and Tissue Sealing Agents Industry: SWOT Analysis
  • Figure 87: Global: Hemostasis and Tissue Sealing Agents Industry: Value Chain Analysis
  • Figure 88: Global: Hemostasis and Tissue Sealing Agents Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Hemostasis and Tissue Sealing Agents Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Hemostasis and Tissue Sealing Agents Market Forecast: Breakup by Product Type (in Million US$), 2024-2032
  • Table 3: Global: Hemostasis and Tissue Sealing Agents Market Forecast: Breakup by Material Type (in Million US$), 2024-2032
  • Table 4: Global: Hemostasis and Tissue Sealing Agents Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 5: Global: Hemostasis and Tissue Sealing Agents Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 6: Global: Hemostasis and Tissue Sealing Agents Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 7: Global: Hemostasis and Tissue Sealing Agents Market: Competitive Structure
  • Table 8: Global: Hemostasis and Tissue Sealing Agents Market: Key Players